Details:
Asset: Pfizer Ltd (PFIZER)
Breakout Level: 4400 (Channel breakout), strong sustain above 5300
Potential Targets: 5600, 6500
Stop Loss: Below 5100
Timeframe: Medium to Long Term
Rationale: Pfizer gave a clear channel breakout at 4400 and has now convincingly sustained above 5300, indicating strong institutional accumulation and upside potential.
Market Analysis:
Technical Setup: Channel breakout with follow-through price action and no signs of weakness above 5300.
Sector Outlook: Positive long-term outlook for pharma sector with rising healthcare demand and export momentum.
Risk Management:
Use SL below 5100 to guard against potential pullbacks.
Timeframe:
Medium to long-term targets of 5600 and 6500 look achievable if current levels hold.
Risk-Reward Ratio:
Strong risk-reward with breakout structure intact and long consolidation base formed below.
Watch for continued volumes and bullish momentum to validate the move further.
Asset: Pfizer Ltd (PFIZER)
Breakout Level: 4400 (Channel breakout), strong sustain above 5300
Potential Targets: 5600, 6500
Stop Loss: Below 5100
Timeframe: Medium to Long Term
Rationale: Pfizer gave a clear channel breakout at 4400 and has now convincingly sustained above 5300, indicating strong institutional accumulation and upside potential.
Market Analysis:
Technical Setup: Channel breakout with follow-through price action and no signs of weakness above 5300.
Sector Outlook: Positive long-term outlook for pharma sector with rising healthcare demand and export momentum.
Risk Management:
Use SL below 5100 to guard against potential pullbacks.
Timeframe:
Medium to long-term targets of 5600 and 6500 look achievable if current levels hold.
Risk-Reward Ratio:
Strong risk-reward with breakout structure intact and long consolidation base formed below.
Watch for continued volumes and bullish momentum to validate the move further.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.